Pittsburgh to Build New Cancer Center

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 1
Volume 8
Issue 1

PITTSBURGH-To accommodate the growth of the University of Pittsburgh Cancer Institute’s (UPCI’s) treatment and research activities, the UPMC Health System will build a 295,000 square-foot integrated facility on the UPMC Shadyside campus. This $104 million building will serve as the hub for UPCI’s clinical programs and scientific investigations.

PITTSBURGH—To accommodate the growth of the University of Pittsburgh Cancer Institute’s (UPCI’s) treatment and research activities, the UPMC Health System will build a 295,000 square-foot integrated facility on the UPMC Shadyside campus. This $104 million building will serve as the hub for UPCI’s clinical programs and scientific investigations.

UPCI includes more than 600 scientists and health care professionals in more than 30 disciplines. It is the only NCI-designated comprehensive cancer center in western Pennsylvania.

“This new building symbolizes the commitment of the UPMC Health System to combat this disease, which touches every family and which is the second-leading cause of death in the United States,” said Jeffrey Romoff, president of the UPMC.

The new building will more than double current research space and allow for the recruitment of 250 new scientists and clinicians. Groundbreaking on the building will begin in the spring of this year.

Recent Videos
3 experts in this video
3 experts in this video
Investigators are currently evaluating mosunetuzumab in relapsed disease or comparing it with rituximab in treatment-naïve follicular lymphoma.
3 experts in this video
3 experts in this video
Compared with second-generation tyrosine kinase inhibitors, asciminib was better tolerated in patients with chronic myeloid leukemia.
The 2 main pafolacianine components, a folate analog and a dye, are commonly used in other medical applications.
Related Content